Sales & Marketing The drug pricing discussion that won’t disappear Discussions of the pharma industry in the political sphere have lingered on pricing for a number of years.
News Sanders calls on FDA to allow low-cost rivals to $375k Catal... US Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Catalyst Pharma’s rare disease drug Firdapse, which is at the heart of a
News Marathon halts launch of Duchenne drug after price outcry Company says it will listen to concerns of patient advocates
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face